Virtual Radiologic Corp. (VRAD), a provider of teleradiology services, Monday said it received U.S. FDA clearance for its own developed Picture Communications and Archiving System or vRad PACS.
The company will roll out the software to its affiliated radiologists over the next several months, gradually replacing the commercial software it currently licenses.
According to Virtual Radiologic, it has over 135 contracted affiliated radiologists located across the nation who would interpret over two and a half million diagnostic images this year through its teleradiology technology and proprietary workflow platform.
vRad PACS incorporates a number of features suggested by these radiologists for ease of use and reading efficiency, the company said.
"vRad PACS completes our strategy of developing our own software to precisely fit the business processes and needs of Virtual Radiologic. Our teleradiology technology platform has been 'designed by radiologists for radiologists', which we believe provides a significant competitive advantage,'' Rick Jennings, chief technology officer of Virtual Radiologic, said.
VRAD is currently trading at $6.87, down $0.09 or 1.29%, from the previous close.
For comments and feedback: editorial@rttnews.com